Vicarious Surgical updates investor presentation

Vicarious Surgical Inc. filed a current report to let investors know it has updated its investor presentation as of September 8, 2025.

Rhea-AI Filing Summary

Vicarious Surgical Inc. filed a current report to let investors know it has updated its investor presentation as of September 8, 2025. Senior management plans to use this updated presentation in meetings with investors and analysts, including at the H.C. Wainwright 27th Annual Global Investment Conference in New York, where Chief Executive Officer Stephen From is scheduled to present at approximately 9:00 a.m. Eastern Time on September 10, 2025.

The updated investor presentation is available on the company’s investor relations website and is also furnished as Exhibit 99.1 to this report. The company notes that the presentation is furnished, not filed, which means it is not subject to certain liability provisions of the Securities Exchange Act and is not automatically incorporated into other securities filings unless specifically referenced.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Vicarious Surgical Inc. (RBOT) disclose in this 8-K filing?

Vicarious Surgical Inc. disclosed that it updated its investor presentation as of September 8, 2025, and that its senior management intends to use this presentation in communications with investors and analysts.

Where can investors find the updated Vicarious Surgical (RBOT) investor presentation?

The updated investor presentation is available on Vicarious Surgical’s investor relations website at https://investor.vicarioussurgical.com/events-and-presentations/ and is also furnished as Exhibit 99.1 to this report.

What event will Vicarious Surgical’s CEO attend according to this 8-K?

Chief Executive Officer Stephen From will present at the H.C. Wainwright 27th Annual Global Investment Conference, held September 8-10, 2025, at the Lotte New York Palace Hotel in New York City.

When is the Vicarious Surgical CEO scheduled to present at the H.C. Wainwright conference?

Stephen From is scheduled to present at approximately 9:00 a.m. Eastern Time on September 10, 2025.

Is the Vicarious Surgical investor presentation considered filed with the SEC?

No. The company states that the information in the investor presentation, furnished as Exhibit 99.1, is furnished and not filed for purposes of Section 18 of the Exchange Act and is not subject to those liabilities or incorporated into other filings unless specifically referenced.

What exhibits are included with this Vicarious Surgical (RBOT) 8-K?

The filing includes Exhibit 99.1, the investor presentation, and Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/08/2025 - 06:38 AM Learn about SEC filing dates

false 0001812173 0001812173 2025-09-08 2025-09-08 0001812173 RBOT:ClassCommonStockParValue0.0001PerShareMember 2025-09-08 2025-09-08 0001812173 RBOT:WarrantsToPurchaseOneShareOfClassCommonStockEachAtExercisePriceOf11.50PerShareMember 2025-09-08 2025-09-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 8, 2025

VICARIOUS SURGICAL INC.

(Exact name of registrant as specified in its charter)

Delaware		001-39384		87-2678169
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

78 Fourth Avenue
Waltham, Massachusetts		02451
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (617) 868-1700

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class A common stock, par value $0.0001 per share		RBOT		The New York Stock Exchange
Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share		RBOT WS		The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01. Regulation FD Disclosure.

As of September 8, 2025, Vicarious Surgical Inc. (the “Company”) updated its investor presentation (the “Presentation”), which its senior management intends to use from time to time when interacting with investors and analysts, among others, including at the H.C. Wainwright 27^th Annual Global Investment Conference, being held September 8-10, 2025, at the Lotte New York Palace Hotel in New York City, at which Stephen From, Chief Executive Officer of the Company, will be presenting at approximately 9:00 a.m. Eastern Time on September 10, 2025. The Presentation is available on the Company’s website at https://investor.vicarioussurgical.com/events-and-presentations/. A copy of the Presentation is also furnished hereto as Exhibit 99.1.

The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Investor Presentation
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	VICARIOUS SURGICAL INC.
	By:	/s/ Stephen From
	Name:	Stephen From
	Title:	Chief Executive Officer

Date: September 8, 2025

2